Suppr超能文献

人类结直肠癌发生过程中端粒酶活性的变化。

Change in telomerase activity during human colorectal carcinogenesis.

作者信息

Yoshida R, Kiyozuka Y, Ichiyoshi H, Senzaki H, Takada H, Hioki K, Tsubura A

机构信息

Department of Pathology II, Kansai Medical University, Osaka, Japan.

出版信息

Anticancer Res. 1999 May-Jun;19(3B):2167-72.

Abstract

Telomerase activities in endoscopically resected colorectal adenomas, surgically resected colorectal cancers and adjacent normal colonic mucosa were examined semiquantitatively by a polymerase chain reaction-based telomeric repeat amplification protocol (TRAP) assay. All normal mucosa (n = 15) presented weak telomerase activity (mean +/- SE: 0.99 +/- 0.00). When the value of 1.00 was arbitrary given to the mean activity of normal mucosa, the telomerase activity in the adenomas (n = 14) was up-regulated (2.01 +/- 0.22) relative to the normal mucosa. The telomerase activity in the high-grade atypia (severe atypia and carcinoma in situ) (2.58 +/- 0.34) was significantly higher than that in the low-grade (mild and moderate) atypia (1.59 +/- 0.18) (P < 0.05), and the adenomas 10 mm or more in diameter presented significantly higher telomerase activity (2.56 +/- 0.09) than compared to the smaller ones (1.44 +/- 0.17) (p < 0.05). Carcinomas (n = 20), showed a telomerase activity that varied from 0.97 to 16.93, which was than the greater mean telomerase activity (6.96 +/- 1.25) noted in the adenomas. The telomerase activity in the carcinomas tended to be higher in the larger (> or = 4 cm), histologically less-differentiated (moderately differentiated), late-stage (Dukes C + D), and nodal metastatic tumors, suggestive of unfavorable prognosis. These results suggests that the weak telomerase activity in normal colonic mucosa is gradually activated during the course of colorectal carcinogenesis.

摘要

采用基于聚合酶链反应的端粒重复序列扩增法(TRAP)半定量检测内镜下切除的大肠腺瘤、手术切除的大肠癌及癌旁正常结肠黏膜中的端粒酶活性。所有正常黏膜(n = 15)端粒酶活性均较弱(均值±标准误:0.99±0.00)。若将正常黏膜的平均活性值设定为1.00,则腺瘤(n = 14)中的端粒酶活性相对于正常黏膜上调(2.01±0.22)。高级别异型增生(重度异型增生和原位癌)中的端粒酶活性(2.58±0.34)显著高于低级别(轻度和中度)异型增生中的活性(1.59±0.18)(P < 0.05),直径10 mm及以上的腺瘤端粒酶活性(2.56±0.09)显著高于较小腺瘤(1.44±0.17)(P < 0.05)。20例癌组织端粒酶活性在0.97至16.93之间,高于腺瘤中的平均端粒酶活性(6.96±1.25)。癌组织中,较大(≥4 cm)、组织学分化程度较低(中度分化)、晚期(Dukes C + D期)及有淋巴结转移的肿瘤端粒酶活性往往较高,提示预后不良。这些结果表明,正常结肠黏膜中的弱端粒酶活性在大肠癌发生过程中逐渐被激活。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验